[go: up one dir, main page]

GB2327611B - Macrolide compositions - Google Patents

Macrolide compositions

Info

Publication number
GB2327611B
GB2327611B GB9818245A GB9818245A GB2327611B GB 2327611 B GB2327611 B GB 2327611B GB 9818245 A GB9818245 A GB 9818245A GB 9818245 A GB9818245 A GB 9818245A GB 2327611 B GB2327611 B GB 2327611B
Authority
GB
United Kingdom
Prior art keywords
macrolide compositions
macrolide
compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
GB9818245A
Other versions
GB2327611A (en
GB9818245D0 (en
Inventor
Barbara Haeberlin
Sylvain Cottens
Richard Sedrani
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Novartis AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB9421613A external-priority patent/GB9421613D0/en
Application filed by Novartis AG filed Critical Novartis AG
Priority to GB9818245A priority Critical patent/GB2327611B/en
Priority claimed from GB9707483A external-priority patent/GB2308545B/en
Publication of GB9818245D0 publication Critical patent/GB9818245D0/en
Publication of GB2327611A publication Critical patent/GB2327611A/en
Application granted granted Critical
Publication of GB2327611B publication Critical patent/GB2327611B/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4858Organic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/436Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13Cyclosporins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12Carboxylic acids; Salts or anhydrides thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/107Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Dispersion Chemistry (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
GB9818245A 1994-10-26 1995-10-25 Macrolide compositions Expired - Lifetime GB2327611B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB9818245A GB2327611B (en) 1994-10-26 1995-10-25 Macrolide compositions

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9421613A GB9421613D0 (en) 1994-10-26 1994-10-26 Organic compounds
GB9707483A GB2308545B (en) 1994-10-26 1995-10-25 Pharmaceutical microemulsion preconcentrates
GB9818245A GB2327611B (en) 1994-10-26 1995-10-25 Macrolide compositions

Publications (3)

Publication Number Publication Date
GB9818245D0 GB9818245D0 (en) 1998-10-14
GB2327611A GB2327611A (en) 1999-02-03
GB2327611B true GB2327611B (en) 1999-06-02

Family

ID=26305872

Family Applications (1)

Application Number Title Priority Date Filing Date
GB9818245A Expired - Lifetime GB2327611B (en) 1994-10-26 1995-10-25 Macrolide compositions

Country Status (1)

Country Link
GB (1) GB2327611B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI307277B (en) * 2002-07-30 2009-03-11 Wyeth Corp Parenteral formulations
CN115192525A (en) * 2021-04-29 2022-10-18 湖南慧泽生物医药科技有限公司 Self-microemulsion composition of sirolimus and preparation method thereof

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1375986A (en) * 1966-04-25 1974-12-04 Schmid Inc Julius Polyenic macrolide composition
EP0010437A2 (en) * 1978-10-20 1980-04-30 Eli Lilly And Company Stable erythromycin solution and process therefor
EP0139891A2 (en) * 1983-08-04 1985-05-08 B.T.B. INDUSTRIA CHIMICA S.p.A. Pharmaceutical compositions with antibiotic-immunostimulating activity
WO1990003793A1 (en) * 1988-10-07 1990-04-19 Rajan Madhok Compositions containing cyclosporins
EP0474126A1 (en) * 1990-09-04 1992-03-11 Fujisawa Pharmaceutical Co., Ltd. Ointments containing tricyclic compound
WO1995004551A1 (en) * 1993-08-10 1995-02-16 Fujisawa Pharmaceutical Co., Ltd. Percutaneously absorbable preparation
EP0694308A1 (en) * 1994-02-17 1996-01-31 Shiseido Company Limited Cyclosporin-containing emulsion composition

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1375986A (en) * 1966-04-25 1974-12-04 Schmid Inc Julius Polyenic macrolide composition
EP0010437A2 (en) * 1978-10-20 1980-04-30 Eli Lilly And Company Stable erythromycin solution and process therefor
EP0139891A2 (en) * 1983-08-04 1985-05-08 B.T.B. INDUSTRIA CHIMICA S.p.A. Pharmaceutical compositions with antibiotic-immunostimulating activity
WO1990003793A1 (en) * 1988-10-07 1990-04-19 Rajan Madhok Compositions containing cyclosporins
EP0474126A1 (en) * 1990-09-04 1992-03-11 Fujisawa Pharmaceutical Co., Ltd. Ointments containing tricyclic compound
WO1995004551A1 (en) * 1993-08-10 1995-02-16 Fujisawa Pharmaceutical Co., Ltd. Percutaneously absorbable preparation
EP0694308A1 (en) * 1994-02-17 1996-01-31 Shiseido Company Limited Cyclosporin-containing emulsion composition

Also Published As

Publication number Publication date
GB2327611A (en) 1999-02-03
GB9818245D0 (en) 1998-10-14

Similar Documents

Publication Publication Date Title
ZA957233B (en) Topically-effective compositions
EG20929A (en) Cleasing compositions
GB9408545D0 (en) Compositions
EG20993A (en) Cleasing compositions
EG20989A (en) Cleasing compositions
GB9613043D0 (en) Improved compositions
ZA951012B (en) Composition
GB9600426D0 (en) Compositions
GB9500577D0 (en) Compositions
GB9504996D0 (en) Compositions
GB9415810D0 (en) Composition
GB9516371D0 (en) Compositions
GB9409543D0 (en) Compositions
GB9502770D0 (en) Amine-curable compositions
ZA954709B (en) Mineral-fiber compositions
HUP9601550A2 (en) Particulale compositions
GB2290299B (en) Anti-lubricant compositions
GB9515805D0 (en) Compositions
GB9416768D0 (en) Compositions
EP0705632A3 (en) 2-Methylpropenyl-terminated polyisobutylene-polydimethyl-siloxane compositions
GB2327611B (en) Macrolide compositions
GB9410139D0 (en) Hebicidal composition
GB9416767D0 (en) Compositions
GB9604856D0 (en) Compositions
GB9600545D0 (en) Compositions